MedTrace Logo

Person-centred Interactive Self-management Support in Primary Healthcare for People With Type 2 Diabetes

NCT03165084 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2017-05-24

No results posted yet for this study

Summary

The aim of this study is to develop and evaluate a person-centred digital intervention in primary healthcare for people with T2D, in addition to their usual diabetes care.

Conditions

  • Diabetes Type 2

Interventions

BEHAVIORAL

Intervention arm: Person-centred interactive self-management support

Person-centred tailored digital self-management support hypothesised to decrease HbA1c, improve other metabolic measurements, improve lifestyle habits, and increase diabetes empowerment, increase diabetes-dependent quality of life, improve illness perception, and improve eHealth literacy. Access to the diabetes mobile application and the homepage during 16 weeks. Each individual will set personal goals for use of the digital resources.

OTHER

Control arm

Participants will receive usual care and take part in a minimal intervention in the form of a brochure on the importance of self-management in diabetes.

OTHER

External comparison group

External comparison groups in order to analyse possible Hawthorne effects.

Sponsors & Collaborators

  • The Swedish Diabetes Foundation

    collaborator UNKNOWN

  • The County Council of Västerbotten

    collaborator UNKNOWN

  • Umeå University

    lead OTHER

Principal Investigators

  • Åsa Hörnsten, Professor · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-05
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03165084 on ClinicalTrials.gov